Chemotherapy safety for staff, canine lymphoma, mast cell tumors, and palliative and quality-of-life care.
Written for: General practitioners who diagnose, stage, co-manage, and sometimes treat, and the staff who handle the drugs.
Cancer care in general practice starts with a fine needle aspirate and a conversation. Most oncology patients are first identified in primary care, many are co-managed with a specialist, and a meaningful number are treated entirely by their regular veterinarian because referral is out of reach for the client. This hub is written for that reality. It covers what the published guidelines say a general practice needs to know to diagnose, stage, explain options, handle chemotherapy drugs safely, and support the patient and client when the goal shifts to comfort.
The field's reference documents include the AAHA oncology guidelines for dogs and cats and the ACVIM consensus statement on the safe use of cytotoxic chemotherapeutics in veterinary practice. Our guides draw on the consensus statements and reviews we could read in full, listed on each page, and on the primary literature on the two canine tumors a small animal clinic meets most often: multicentric lymphoma and cutaneous mast cell tumors. For lymphoma, the guides describe staging, immunophenotype, and the multi-agent protocols that the literature treats as the standard of comparison, with remission and survival figures quoted from the studies that reported them. For mast cell tumors, they explain the two histologic grading systems in use, what each predicts, and how grade, location, and margins enter the treatment decision as the published consensus documents describe it.
Staff safety has its own guide because it concerns everyone in the building. Cytotoxic drugs are hazardous to the people who prepare, administer, and clean up after them, and the ACVIM consensus statement and published occupational health evaluations describe specific controls: where drugs are prepared, what protective equipment is worn, how waste and patient excreta are handled, and which staff should not be handling these agents at all. The guide reports those recommendations with attribution and does not add requirements of its own. Regulatory obligations vary by state and by the compounding standards a state has adopted, and the guide points to the regulators for the binding rules.
Palliative care and quality-of-life assessment close the hub. Published hospice and palliative care guidelines, including those of the International Association for Animal Hospice and Palliative Care, describe structured quality-of-life tools, pain and symptom control, and the conversations that precede euthanasia decisions. Survival statistics in oncology are medians from specific study populations, and the guides present them that way, with the sample size and design alongside each number. They are context for a conversation with a client, and they do not predict the course of an individual patient.
Preparation, administration, spill and waste handling, and staff exclusions as the consensus statement describes them.
Diagnosis, staging, grading, and the treatment approaches the literature describes for lymphoma and mast cell tumors.
Quality-of-life tools, symptom control, and end-of-life planning.